MedTrace Logo

Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men

NCT00470873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2471

Last updated 2014-12-02

No results posted yet for this study

Summary

The primary aim of this open, uncontrolled, prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfunction. The secondary aim of this study is to assess the influence of the treatment with Levitra on self-esteem (depressive symptomology) in men with ED.

Conditions

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

Primary care erectile dysfunction patients for whom physician decided to start the treatment with vardenafil

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2008-02-29

Countries

  • Poland

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00470873 on ClinicalTrials.gov